DPG Mitgliedschaft
This block is broken or missing. You may be missing content or you might need to enable the original module.
Keyword: Shire
News
17.01.2020
- Japanese drugmaker Takeda is facing a large tax bill from Ireland as an uncalculated repercussion of its acquisition of US-managed, Ireland-domiciled Shire at the end of 2018. Tax...
Topstories
06.12.2019
- The chemical, pharmaceutical and life sciences industries in Switzerland — organized in the Scienceindustries trade association — account for 45% of total exports with around 70...
News
21.10.2019
- In another move to reduce debt after buying Shire early this year, Japanese drugmaker Takeda has agreed to sell roughly 30 prescription pharmaceuticals and over-the-counter (OTC)...
Topstories
13.09.2019
- Abbvie takes over Allergan, Pfizer merges its generics business with Mylan, Takeda integrates Shire — the pharmaceutical industry is making a name for itself in 2019 with several...
News
13.05.2019
- To lighten its debt burden of more than $30 billion resulting from last year’s acquisition of Shire, Japanese pharma giant Takeda is selling Shire’s dry-eye drug Xiidra to...
News
06.12.2018
- Shareholders of Japanese drugmaker Takeda and Netherlands-domiciled, US-managed Shire have separately approved the merger of the two pharmaceutical manufacturers. All regulatory...
News
23.11.2018
- European regulators have approved Takeda’s proposed acquisition of its US rival Shire, clearing the way for the £46 billion deal to complete. The clearance is conditional on both...
News
01.11.2018
- Japanese drugmaker Takeda has confirmed it is talking to the European Commission about selling Shire’s inflammatory bowel disease candidate SHP647, along with some associated...
Ehrenamtliches Engagement
This block is broken or missing. You may be missing content or you might need to enable the original module.
